• Sonuç bulunamadı

ANNOUNCEMENTS/DUYURULAR

N/A
N/A
Protected

Academic year: 2021

Share "ANNOUNCEMENTS/DUYURULAR "

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

ANNOUNCEMENTS/DUYURULAR

FIP CONGRESS 2000, VIENNA The Industrial Highlights

Fara full prograrnme go to www.fip.nl.

Monday August 28

14 - 17 pm The impact of new science and technology on pharmacy practice

L Advances in drug science in !he new decade / Douwe Breimer, The Netherlands

2. Opportunities in screening and monitoring / TBA

3. _ The challenge of genomicn in drug therapy -can we afford it? / François Schubert, Canada Evening: Welcome Reception at City Hali Tuesday August 29

Evening: Viennese concert at "Musikverein" (FIP) Wednesday August 30

09 - 12 anı Good Storage Practices

L Presentation of !he FIP /WHO guideline (key-elements) on Good Storage Practices (Helga Möller)

2. ICH concept lor stability testing and FIP /WHO recommendations: an international approach for storage and labelling? Frans Pieters (Quality Working Party, NV Organon)

3. USP vs FIP /WHO recoınmendations: How to harmonise? Claudia Okeke (USP)

4. EU vs FIP /WHO recornmendations: How to harmonise? Rickard Wanko (Bundesinstitul für Arzneimittel)

- 5. International Perspectives of WHO, Sabine Kopp-Kubel (WHO, Switzerland)

12 - 14 pm Industrial poster session 1

14 - 17 pm lnternational Harmonisation of Quality

84

Characteristics lor Parenterals

l. Status of Harmonised Monographs: Sterility Testing, Bacterial Endotoxins, Microbial Contamination, Peter Cooney (FDA, USA) 2. Preservative Efficacy Testing AL. Davidson (UK) 3. Particulate Matter Testing, Mike Groves (USA) 4. Parametric Release, Klaus Haberer (Compliance,

Germany)

Evening : IPS Section dinner Thursday August 31

09 - 12 am Barrier Isolation Technology - The Future lor Parenteral Production?

L The design of Barrier Technology, Jack Lysjfjord (Bosch/TL Systems, USA)

2. Vial filling !ine to autonıatically load freeze dryer utelizing barrier isolators, Charlotte Enghave (Novo Nordisk Engineering A/S, Denmark) 3. GMP aspects, Andreas Wirth (Novartis Pharma

Stein AG, Switzerland)

4. Regulatory aspects, Peter Cooney (FDA) 12 - 14 pm Industrial poster session 2 14 - 17 pm IPS Business Meeting L Industrial poster award winner

2. Presentation by Prof. Leuenberger, IPS medal winner

3. Treasmer's report

4. Member assembly /Election of new ExCo rnembers

5. Tea

6. Status of Working Groups and Special Interest Groups (Helga Möller)

7. Preview on Singapore/The Pharmaceutical Industry in South-East Asia

Gala dinner

Referanslar

Benzer Belgeler

This paper aims to look at (a) Turkish political context and the reasons behind the rise of anti-Westernism and Euroscepticism in the post-July 15 period and (b) the possible

From the study, it has been found that 98% of the male and 100% of the female students think that there is a need to create social awareness regarding human rights.. From the study,

Dersin Amacı Sağlığı korumak ve geliştirmek amaçlı fitness değerlendirmeleri yapabilme k ve egzersiz recetesi hazırlayabilmek Dersin Süresi 90 Dakika. Eğitim Dili

lantılar arasında ; 'History of pharmacy', 'The role of oxidants', 'Ethical issues in the use and provision of information', 'Setting specifications for excipients and

If the saving list is computed by considering higher quality parameters, such as the three best parameter vectors obtained after the genetic algorithm (ie, the first three parameter

Related to this statement, the manifesto defines citizenship not as a “symbolic legal status” but as a “political opportunity that empowers individuals in terms of

On the other hand T44 is the largest block in the Famagusta Old town with its large and irregular plot formation, ecclesial ruins and other public buildings which are located in

International Conference on Harmonisation (ICH), “Bracketing and matrixing design for stability testing of new drug substances and products”, ICH Harmonised Tripartite Guideline,